Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$32.4 - $68.18 $427,323 - $899,226
13,189 Added 3.49%
391,051 $26.6 Million
Q2 2022

Aug 12, 2022

BUY
$22.3 - $37.39 $569,252 - $954,454
25,527 Added 7.25%
377,862 $12.1 Million
Q1 2022

May 11, 2022

SELL
$25.68 - $35.59 $36,208 - $50,181
-1,410 Reduced 0.4%
352,335 $12.2 Million
Q4 2021

Feb 07, 2022

BUY
$24.9 - $40.26 $291,828 - $471,847
11,720 Added 3.43%
353,745 $10.4 Million
Q3 2021

Nov 10, 2021

SELL
$25.48 - $37.34 $8,433 - $12,359
-331 Reduced 0.1%
342,025 $8.72 Million
Q2 2021

Aug 05, 2021

BUY
$32.46 - $43.42 $4.37 Million - $5.85 Million
134,684 Added 64.85%
342,356 $12 Million
Q1 2021

May 14, 2021

BUY
$38.94 - $50.85 $3.11 Million - $4.06 Million
79,887 Added 62.52%
207,672 $8.46 Million
Q4 2020

Feb 12, 2021

BUY
$37.65 - $63.77 $1.6 Million - $2.71 Million
42,459 Added 49.76%
127,785 $5.53 Million
Q3 2020

Nov 13, 2020

SELL
$52.76 - $74.49 $482,279 - $680,913
-9,141 Reduced 9.68%
85,326 $4.71 Million
Q2 2020

Aug 13, 2020

SELL
$48.73 - $81.82 $310,263 - $520,947
-6,367 Reduced 6.31%
94,467 $5.96 Million
Q1 2020

May 14, 2020

SELL
$41.72 - $87.2 $216,902 - $453,352
-5,199 Reduced 4.9%
100,834 $5.15 Million
Q4 2019

Feb 12, 2020

BUY
$45.7 - $81.86 $1.86 Million - $3.33 Million
40,715 Added 62.33%
106,033 $8.43 Million
Q3 2019

Nov 13, 2019

BUY
$45.35 - $57.91 $174,416 - $222,721
3,846 Added 6.26%
65,318 $3.17 Million
Q2 2019

Aug 14, 2019

BUY
$52.6 - $63.29 $751,811 - $904,603
14,293 Added 30.3%
61,472 $3.23 Million
Q1 2019

May 14, 2019

SELL
$39.99 - $53.48 $350,392 - $468,591
-8,762 Reduced 15.66%
47,179 $0
Q4 2018

Feb 13, 2019

SELL
$31.54 - $46.67 $92,759 - $137,256
-2,941 Reduced 4.99%
55,941 $2.3 Million
Q3 2018

Nov 02, 2018

SELL
$38.0 - $51.1 $15,922 - $21,410
-419 Reduced 0.71%
58,882 $2.24 Million
Q2 2018

Aug 08, 2018

BUY
$38.7 - $50.15 $2.29 Million - $2.97 Million
59,301 New
59,301 $2.68 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.